1. Home
  2. FRMM vs PYPD Comparison

FRMM vs PYPD Comparison

Compare FRMM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$6.07

Market Cap

75.7M

Sector

Health Care

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$5.06

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMM
PYPD
Founded
N/A
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.7M
71.7M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
FRMM
PYPD
Price
$6.07
$5.06
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$12.25
AVG Volume (30 Days)
180.0K
183.4K
Earning Date
05-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,547,000.00
N/A
Revenue This Year
$183.55
N/A
Revenue Next Year
$166.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$3.06
52 Week High
$7.15
$5.73

Technical Indicators

Market Signals
Indicator
FRMM
PYPD
Relative Strength Index (RSI) 53.59 59.61
Support Level $4.90 $4.18
Resistance Level $6.47 $5.67
Average True Range (ATR) 0.44 0.26
MACD -0.02 0.06
Stochastic Oscillator 71.47 96.30

Price Performance

Historical Comparison
FRMM
PYPD

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: